Author
Listed:
- Lars Velten
(Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology
Universitat Pompeu Fabra (UPF))
- Benjamin A. Story
(European Molecular Biology Laboratory (EMBL), Genome Biology Unit
Swiss Federal Institute of Technology (ETH) Zurich, Department of Biosystems Science and Engineering)
- Pablo Hernández-Malmierca
(Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH)
Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ) and DKFZ-ZMBH Alliance)
- Simon Raffel
(Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH)
Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ) and DKFZ-ZMBH Alliance
University of Heidelberg)
- Daniel R. Leonce
(European Molecular Biology Laboratory (EMBL), Genome Biology Unit)
- Jennifer Milbank
(European Molecular Biology Laboratory (EMBL), Genome Biology Unit)
- Malte Paulsen
(European Molecular Biology Laboratory (EMBL), Flow Cytometry Core Facility)
- Aykut Demir
(University of Heidelberg)
- Chelsea Szu-Tu
(Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology
Universitat Pompeu Fabra (UPF))
- Robert Frömel
(Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology
Universitat Pompeu Fabra (UPF))
- Christoph Lutz
(University of Heidelberg)
- Daniel Nowak
(Medical Faculty Mannheim, Heidelberg University)
- Johann-Christoph Jann
(Medical Faculty Mannheim, Heidelberg University)
- Caroline Pabst
(University of Heidelberg
University of Heidelberg and European Molecular Biology Laboratory (EMBL))
- Tobias Boch
(Swiss Federal Institute of Technology (ETH) Zurich, Department of Biosystems Science and Engineering
Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ) and DKFZ-ZMBH Alliance
Medical Faculty Mannheim, Heidelberg University)
- Wolf-Karsten Hofmann
(Medical Faculty Mannheim, Heidelberg University)
- Carsten Müller-Tidow
(University of Heidelberg)
- Andreas Trumpp
(Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH)
Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ) and DKFZ-ZMBH Alliance
German Cancer Consortium (DKTK))
- Simon Haas
(Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH)
Division of Stem Cells and Cancer, Deutsches Krebsforschungszentrum (DKFZ) and DKFZ-ZMBH Alliance
German Cancer Consortium (DKTK)
Berlin Institute of Health (BIH))
- Lars M. Steinmetz
(European Molecular Biology Laboratory (EMBL), Genome Biology Unit
Stanford University School of Medicine
Stanford Genome Technology Center)
Abstract
Cancer stem cells drive disease progression and relapse in many types of cancer. Despite this, a thorough characterization of these cells remains elusive and with it the ability to eradicate cancer at its source. In acute myeloid leukemia (AML), leukemic stem cells (LSCs) underlie mortality but are difficult to isolate due to their low abundance and high similarity to healthy hematopoietic stem cells (HSCs). Here, we demonstrate that LSCs, HSCs, and pre-leukemic stem cells can be identified and molecularly profiled by combining single-cell transcriptomics with lineage tracing using both nuclear and mitochondrial somatic variants. While mutational status discriminates between healthy and cancerous cells, gene expression distinguishes stem cells and progenitor cell populations. Our approach enables the identification of LSC-specific gene expression programs and the characterization of differentiation blocks induced by leukemic mutations. Taken together, we demonstrate the power of single-cell multi-omic approaches in characterizing cancer stem cells.
Suggested Citation
Lars Velten & Benjamin A. Story & Pablo Hernández-Malmierca & Simon Raffel & Daniel R. Leonce & Jennifer Milbank & Malte Paulsen & Aykut Demir & Chelsea Szu-Tu & Robert Frömel & Christoph Lutz & Danie, 2021.
"Identification of leukemic and pre-leukemic stem cells by clonal tracking from single-cell transcriptomics,"
Nature Communications, Nature, vol. 12(1), pages 1-13, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-21650-1
DOI: 10.1038/s41467-021-21650-1
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-21650-1. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.